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The histological appearance of kidneys from patients with
diabetic nephropathy is characterized by a variety of findings.
The most characteristic finding is a diffuse and/or nodular
glomerulosclerosis, consisting of thickening of the peripheral
basement membranes and an increase of the mesangial matrix.
The nodular transformation of the mesangium leads to the
classical Kimmelstiel-Wilson lesion. These typical morphologi-
cal findings have directed attention to the process and nature of
basement membrane thickening. Also, it has been recognized
for a long time that basement membrane thickening is depen-
dent on the duration and metabolic control of diabetes mellitus
[1—41. The question of how basement membrane thickening and
diabetes mellitus are related biochemically was less clear. This
lack of clarity was mainly due to the fact that the chemical
structure of the basement membrane was not known. Earlier
chemical analyses were beset by methodological drawbacks
limiting the value of the results [5, 61, whereas recent studies on
the chemical composition of normal and diabetic human
glomerular basement membranes (HGBM) produced conflicting
results [7—131. The isolation procedure and the source of the
kidneys, as well as other factors, have been considered respon-
sible for the different results obtained by various investigators.
This prompted us to carry out further biochemical analyses on
normal and diabetic HGBM under more carefully controlled
conditions. Special attention has been paid to the source of
kidneys and the evaluation of contamination of the isolated
basement membranes.
Methods
Human kidneys have been obtained at autopsy within 12 hr
following the death of diabetic and nondiabetic subjects. The
kidneys were processed immediately; freezing was avoided.
The 22 diabetic patients, aged 26 to 80 years (median, 66.5) had
a duration of diagnosed diabetes mellitus between 3 and 22
years (median, 10 years). Clinical data on the diabetic patients
are given in Table 1.
The nature and degree of renal changes was evaluated in each
individual patient by histological examination using light mi-
croscopy on 200 randomly selected glomeruli (100 per kidney).
Measurements of mesangial width have been done on periodic
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acid Schiff's reagent (PAS)-stained sections at a magnification
of 420 x. In kidneys with nodular glomeruloscierosis the per-
centage of glomeruli containing noduli was estimated in a total
of 200 glomeruli. All except one diabetic patient had diffuse
and/or nodular glomerulosclerosis of differing degrees of sever-
ity. Classification of the histological alterations was done
according to Ditscherlein [14] (Table 2). About 50% of all the
kidneys from the diabetic patients showed a mesangium width
of more than 20 p.m; the remainder showed even more severe
lesions.
The 32 nondiabetic subjects, between 33 to 87 years of age
(median 60.1), died from diseases unrelated to diabetes mellitus
or kidney diseases; they had no history of diabetes mellitus.
With microscopic examination, the most common histological
finding was a few hyaline glomeruli. There was no difference in
sex and age distributions between the two groups.
Preparation of glomeruli. The isolation procedure followed
was the technique of Krakower and Greenspon [15] as modified
by Spiro [161 and Westberg and Michael [17]. Using this
procedure, the kidney cortex was minced and pressed through a
115-mesh stainless sieve. The bigger tissue fragments were
removed during a passage through an 80-mesh sieve; the
glomeruli are collected on a 150-mesh sieve and washed exten-
sively with cold saline. The absence of tubular remnants and
other tissue fragments in this glomerular preparation was
checked generally by phase contrast microscopy.
Preparation of HGBM. For isolation of basement mem-
branes, glomeruli were disrupted with a Branson sonifier (S
125) at number 6 power setting. The sonication period was
standardized at 7 bursts of 1-mm durations with a cooling period
between the bursts. The glomeruli were suspended in 1 M saline
at a concentration equivalent to 2 g cortex per milliliter. The
HGBM was collected by centrifugation in 1 M sodium chloride
at a very low speed (121 g/15 mm) and washed repeatedly three
times in 1 M sodium chloride and three times in water. Undis-
rupted glomeruli were removed by filtration over a 200-mesh
sieve. Random samples of the isolated HGBM (15%) were
checked by transmission and scanning electronmicroscopy for
impurities. HGBM were then lyophilized and stored under
sealed conditions at — 15° C.
Amino acids. For amino acid analysis HGBM was submitted
to a 24-hr hydrolysis in constant boiling hydrochloric acid at a
concentration of 1 mg HGBM dry weight/l ml at 110° C in
sealed evacuated glass tubes. The hydrochloric acid was evapo-
rated over potassium hydroxide and phosphorus pentoxide.
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Table I. Clinical data on diabetic patients
Patient
no.
Duration of Serum
diabetes mellitus creatinine Type of
Age/Sex years Therapy mg/dl Cause of death glomerulosclerosis
See
Table 2
1 45 M 21 Insulin 2.3 Myocardial infarction Nodular 3
2 67 M 8 Oral agents 2.5 Myocardial infarction Diffuse 3
3 30 F 20 Insulin 9.2 Uremia Diffuse 5
4 76 M 10 Insulin 1.9 Apoplexia Diffuse 3
5 52 F 10 insulin 1.4 Myocardial infarction Diffuse Ito 2
6 80 F 3 Diet 1.2 Myocardial infarction Diffuse I to 2
7 65 M 3 Oral agents 2.0 Uremia Diffuse 4
8 79 F 10 Oral agents 1.8 Pneumonia Diffuse 3
9 78 F 15 Insulin 1.5 Myocardial infarction Diffuse 4
10 78 M 10 Oral agents 1.7 Pneumonia Diffuse Ito 2
11 78 M 3 Diet 2.4 Pulmonary embolism Diffuse Ito 2
12 70 M 10 Insulin 2.2 Apoplexia Nodular 1 to 2
13 76 F 15 Insulin 1.1 Pulmonary embolism Diffuse 1 to 2
14 63 M 10 Oral agents 1.8 Sepsis Diffuse Ito 2
15 68 F 3 Insulin 1.2 Cancer of esophagus None
16 65 F 10 Insulin 11.6 Uremia Diffuse 5
17 66 F 19 Oral agents 1.2 Diabetic coma Nodular Ito 2
18 26 F 16 Insulin 4.5 Myocardial infarction Nodular 5
19 43 M 25 Insulin 1.5 Pneumonia Nodular Ito 2
20 66 F 46 Insulin 2.0 Myocardial infarction Nodular 3
21 66 M 16 Oral agents 4.0 Uremia Diffuse 5
22 66 F 3 Diet 1.2 Breast cancer Diffuse ito 2
Table 2. Classification of diffuse and nodular glomerulosclerosis
Stage Diffuse glomerulosclerosis Stage Nodular glomerulosclerosis
0 Normal histology I to 2 Less than 50% of glomeruli contain noduli
1 to 2 Mesangium width less than 20 im 3 More than 50% of glomeruli contain noduli
3 Mesangium width more than 20 m 4 Like 3 with 20 to 40% of glomeruli hyalinized
4 Like 3 with 20 to 40% of glomeruli hyalinized 5 Like 3 with more than 40% of glomeruli hyalinized
5 Like 3 with more than 40% of glomeruli hyalinized
Fig. 1. Weights of kidneys, cortices and HGBM in diabetics (N = 19)
and normals (N = 32), ( s).
Aminex A6 (15.5 to 19.5 m) was used on a 0.9 x 54cm column
ror the acidic amino acids. The sample was eluted with 0.2 N
sodium citrate buffer first at pH 2.93 and then at pH 3.3 and 4.0
it 550 C. The basic amino acids were separated on a 0.9 X 15 cm
column of Aminex AS (11.5 to 15.5 m) with a 0.4 N sodium
itrate buffer at pH 5.3 at 500 C. Methionine and cystine were
analyzed according to the method described by Moore [18]. All
determinations were run in duplicate on a BC 200 Biocal
Instruments analyser. The average percent differences in indi-
vidual amino acids from the mean was 8% except for histidine
and arginine (27.3 and 25.3%, respectively). Losses during the
analyses were corrected using norleucine as an internal stan-
dard; the mean recovery rate was 97.4%.
Carbohydrates. Glucose, galactose, and mannose were liber-
ated from HGBM by hydrolysis in sulphuric acid at 1000 C over
4 hr in sealed glass tubes. The determination was made in the
neutralized supernatant by commercially available test kits
(Boehringer Mannheim). For the determination of fucose, the
Dische-Shettles cystine reaction was used [19]. Sialic acids
were evaluated according to the method described by Warren
[20].
Other chemical analyses. DNA analyses were performed by
the method of Burton [21]. Total phosphorus was determined
by the method described by Bartlett [22].
Microscopic examination. Transmission and scanning elec-
tronmicroscopic examinations were done as reported previous-
ly [23, 241.
Statistical methods. Except otherwise stated, all values are
given as mean SD ( s). Statistical significance of group
differences was tested by the nonparametric two-tailed Wil-
coxon test for random samples. Correlations were calculated
using linear regression analysis [25].
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Fig. 2. Scanning electronmicroscopic view of
isolated normal HGBM.
Results
Preparations of glomeruli and HGBM. The amount of kidney
cortex isolated from 32 normal kidneys was 50.8/100 g kidney
8.4/100 g kidney. The cortex-weight was recorded in 19 kidneys
with diabetic glomerulosclerosis and amounted to 48.2 g/100 g
of kidney 6.1 g/100 g of kidney. The difference was not
statistically significant. The amount of basement membrane
isolated from 32 normal kidneys was 39.4 mg/100 g of cortex
27.3 mg/l00g of cortex; the median was 31.3 mg/100 g of cortex.
The average yield of basement membranes in the diabetic group
(N = 19) was 90 mgIlOO g of cortex 107 mg/100 g of cortex.
The positive skewness of the distribution of the basement
membrane weights was due to the irregular distribution of the
different grades of severity of diabetic glomerulosclerosis; the
median was 59.1 mg/l00 g of cortex. The yield of HGBM in the
diabetic group was significantly higher (P < 0.01, Fig. 1) than
the yield of the nondiabetic group.
Microscopic examinations. About 15% of the isolated gb-
meruli retained their capsules. When viewed by transmission
electronmicroscopy, the basement membrane appeared as in-
tact dense ribbons with occasional cell remnants attached to it,
devoid of intact collagen fibers. Figure 2 shows a scanning
electronmicroscopic view of isolated normal HGBM.
Chemical composition
DNA and phosphorus contents. The DNA and phosphorus
contents of normal and diabetic HGBM are given in Table 3; no
statistical difference between the two groups was found. When
calculated on the basis of 4-hydroxyproline, the phosphorus
content of diabetic basement membranes was slightly lower
than the normal basement membranes. The difference did not
reach any level of statistical significance.
Amino acid composition. The amino acid composition of
normal and diabetic basement membranes is given in M/l00
mg HGBM in Table 4 and in residues per 1000 amino acid
residues in Table 5. When compared on the basis of p.M/l00 mg
I',
A
fJ
Biochemistry of diabetes mellitus GBM 747
Table 3. DNA and phosphorus content of diabetic and normal
HGBMa
Composition
Diabetic
. SD
Norm
y
al
sn
DNA, p.g/100 mg HGBM 136.54 42.65 134.7 44.5
(tV = II) (PV = 17)
Phosphorus, phosphateig HGBM 16.23 4.72 18.46 7.52(N= 15) (N= 27)
a The N in parentheses represents the number of samples analyzed.
Table 4. Amino acid composition of HGBM, M/100 mg HGBM
Amino acid
Normal, N
X
= 16
su
Diabetic, N
X
= 22
su
3-hydroxyproline 8.93 2.26 8.17 2.23
4-hydroxyproline 60.78 6.49 61.74 10.33
Aspartic acid 48.96 2.81 49.49 3.45
Threonine 24.94 1.94 24.62 2.35
Serine 36.12 2.22 36.24 2.67
Glutamic acid 74.56 5.66 75.54 5.41
Proline 47.03 2.88 46.31 3.79
Glycine 203.85 17.44 200.14 25.31
Alanine 41.52 3.26 41.02 4.98
HaIf-cystine 23.05 4.52 18.66" 6.23
Valine 26.59 1.97 26.77 1.70
Methionine 6.02 3.23 5.46 3.23
Isoleucine 23.46 1.20 24.19 1.61
Leucine 47.74 3.02 47.12 3.56
Tyrosine 11.56 0.91 11.60 1.51
Phenylalanine 24.07 2.05 24.67 2.68
Hydroxylysine
N = 31
20.69 2.56
N = 17
19.45 3.06
Lysine 12.38 1.96 13.24 2.70
Histidine 9.35 1.33 8.92 1.86
Arginine 33.34 3.89 32.21 6.18
a N represents the number of HGBM preparations analyzed.
b P < 0.05
HGBM, the only amino acid behaving differently was half
cystine; when compared on the basis of residues per 1000 amino
acid residues, the diabetic basement membrane showed a
smaller hydroxylysine content. The latter result could have
been influenced by a smaller sample size.
Carbohydrate composition. Carbohydrate composition of
normal diabetic basement membranes is given in Table 6. The
glucose content of the 22 diabetic basement membranes was
slightly lower than in the normal basement membranes (P <
0.05). This significance could also be shown for the mannose
content (P < 0.01). The sialic acid content showed a tendency
toward lower values; the difference between the two groups,
nevertheless, did not reach any level of statistical significance.
Chemicalfindings in a selected subgroup. The great variation
of basement membrane weights, possibly reflecting different
compositions [261, prompted a separate analysis of a group of
eight diabetic basement membrane preparations, Their weight
was double the amount of normal basement membrane. The
mean duration of diabetes mellitus in the group was 14 years; all
kidneys except one showed extremely severe alterations of
diffuse and/or nodular diabetic glomerulosclerosis. The mean
basement membrane yield was 170 mg/l00 g of cortex (median
Table 5. Amino acid composition of HGBM, residues/l000 amino acid
residuesa
Amino acid
Normal,
X
N = 16
SD
Diabetic,
X
N = 17
SD
3-hydroxyproline 11.24 2.42 10.32 2.45
4-hydroxyproline 76.98 6.62 78.85 9.59
Aspartic acids 62.08 2.37 63.85 3.84
Threonine 31.63 2.14 31.62 3.20
Serine 45.78 1.52 46.85 2.82
Glutamic acid 94.43 3.84 97.84 4.51
Proline 59.63 2.42 59.66 3.47
Glycine 258.12 12.89 255.81 17.64
Alanine 52.68 4.02 53.11 6.69
HaIf-cystine 29.21 5.66 23.84" 7.36
Valine 33.75 2.56 34.64 2.46
Methionine 7.60 4.10 7.07 3.95
Isoleucine 29.76 1.37 31.10 2.59
Leucine 60.52 2.34 60.61 3.78
Tyrosine 14.67 1.22 14.87 1.89
Phenylalanine
Hydroxylysine
30.51
28.19
2.04
2.66
32.19
25.68"
3.61
3.86
Lysine 15.73 2.96 17.57 3.94
Histidine 11.64 1.91 11.80 2.51
Arginine 45.84 5.40 4270b 8.94
a N represents the number of HGBM preparations analyzed.
b P < 0.05
113) in the diabetic group and 47 mg/100 mg of cortex (median
43) in the normal group. The latter group, comprising nine
basement membrane preparations, was chosen to match age
and sex. Except for half cystine there was no difference in the
amino acid and carbohydrate composition between the two
groups, irrespective of the calculation mode.
Discussion
The conflicting results concerning the composition of normal
and diabetic HGBM suggest a substantial influence of the
method of isolation and source of basement membranes on the
results obtained. Spiro suggested the use of only those kidneys
which show unequivocal changes characteristic of diabetic
glomerulosclerosis [26]. This study agrees completely with him
on that point. With one exception, all kidneys analyzed in this
study showed severe alterations corresponding to the histologi-
cal picture of diabetic glomerulosclerosis. As expected, the
yield of isolated HGBM depended on the severity of the
histological alteration (r = 0.55, P < 0.01). Contrary to the
contention of other reports [81, it is believed that this yield is
proof for our assumption that the morphological substrate of
diabetic glomerulosclerosis has been isolated and analyzed.
This statement holds true only for the insoluble backbone of the
HGBM due to the inherent limitations of the isolation tech-
nique. Information regarding constituents such as glycosamin-
oglycans [27, 28], P-component [291, and laminin [30, 31] cannot
be obtained. The weights of diabetic kidneys and renal cortices
did not differ from the nondiabetic control subjects; this finding
agrees with evidence shown previously by pathologists [14].
The basement membrane yield of diabetic kidneys, however,
was significantly higher (P < 0.01) than the yield of nondiabetic
kidneys (90.0 vs. 39.4/100 mg HGBM). To our knowledge,
similar findings have only been reported elsewhere by Westberg
and Michael [9] and Cruz and Moreau-Lalande [12].
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Table 6. Carbohydrate composition of HGBM, IiM/g HGBM
Normal Diabetic
Carbohydrate Na A Na X
Glucose 30 154.38 19.12 22 142.29' 24.90
Galactose 30 160.06 19.97 22 149.57 22.33
Mannose 29 40.53 10.03 22 32.44c 8.31
Fucose 21 38.31 9.59 16 37.65 7.30
Sialic acids 29 23.29 3.74 21 20.87d 4.69
a N represents the number of HGBM preparations analyzed.
p < 005
P < 0.01
d p = 0.062
Table 7. Comparison of several studies on the composition of the diabetic HGBM
Beisswenger Westberg and Cruz et
WahI et al
(present
Composition and Spiro [81 Michael [9] Kefalides [10] al [12] observations)
Hydroxyproline + N N N N
Glycine + N N + N
HaIf-cystine N — — — —
Hydroxylysine + N N + N
Lysine — — N N N
Glucose + + N + —
Galactose + N N + N
Mannose N N (—) N —
Sialic acids n.g. — — — (—)
Symbols are: n.g., not given; +, greater than normal; —, less than normal; N, not changed from normal (P < 0.05); (—), statistically not
significant.
To compare analytical results with other published reports,
an identical degree of purity of the isolated HGBM is required.
The phosphorus and DNA content of our HGBM preparations
falls in the lower range of the values reported thus far. There
was no significant difference between the degree of purity of
diabetic and nondiabetic HGBM. Calculated as M/l00 mg
HGBM, the amino acid composition differed only in one amino
acid between diabetic and nondiabetic HGBM. With 19 M/l00
mg HGBM the haif-cystine concentration in diabetic HGBM
was significantly lower compared with nondiabetic HGBM.
Calculated as residues/l000 residues, hydroxylysine and argi-
nine contents were lower in the diabetic HGBM. The lower
half-cystine content agrees with previous studies. Contrary to
Beisswenger and Spiro [8] and Cruz and Moreau-Lalande [12],
this study could not find an increase in the hydroxylysine or a
decrease in lysine content (Table 5). The carbohydrate compo-
sition was slightly different from the composition reported thus
far for normal and diabetic basement membranes. A slight
decrease of the glucose and mannose content was found. The
lower sialic acid content in diabetic HGBM was not significant.
Our data cannot confirm the finding of a specific alteration of
diabetic HGBM as proposed by Beisswenger [32]. They are in
full accordance with those of Westberg and Michael [9], Kefali-
des [10], and partly with Cruz and Moreau-Lalande's [12]
results (Table 7). The results of Sato et a! [11] were not taken
into account because only two patients of their diabetic group
showed histological alterations of glomerulosclerosis, The re-
sults of Canivet, Cruz, and Moreau-Lalande [13] were pub-
lished previously by Cruz and Moreau-Lalande [121. Differ-
ences in the composition that eludes recognition due to the
applied method of isolation cannot be excluded. It is unclear
why most of the published results vary from those of Beiss-
wenger and Spiro 171. Differences in the source of diabetic
kidneys and the isolation procedure could contribute substan-
tially to these different results. This study has tried to exclude
all possible sources of error alluded to by Brownlee and Spiro
[33] without confirming their findings.
Summary. HGBM were isolated from kidneys of 22 diabetic
patients and 32 normal control persons. All diabetic kidneys
showed severe alterations of glomerulosclerosis. The amount of
basement membranes isolated from diabetic kidneys was signif-
icantly higher. The HGBM preparations were individually
analyzed for phosphorus, DNA, amino acids, and carbohy-
drates. The cystine concentration was found to be lower in the
diabetic than in normal HGBM. Contrary to other reports, there
was no increase in the amounts of hydroxylysine, glucose, and
galactose, nor was there a decrease in the lysine content.
Glucose and mannose were shown to be significantly lower in
the diabetic HGBM. The mean value for sialic acid content was
lower in diabetic HGBM; the value did not reach statistical
significance. This study's data could not confirm the finding of a
specific alteration of diabetic HGBM as proposed previously.
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